CorMedix Inc.
CRMD
$8.13
-$0.05-0.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.07% | 86.98% | 4.13% | 4,009.64% | 240.11% |
| Total Depreciation and Amortization | 6,366.26% | 6,408.64% | 7,692.16% | 4,797.29% | 111.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 375.79% | 632.18% | 2,775.25% | -4,515.37% | 108.41% |
| Change in Net Operating Assets | 405.01% | -609.12% | 246.94% | -109.99% | 676.01% |
| Cash from Operations | 187.54% | 114.73% | 1,782.33% | 326.06% | 313.61% |
| Capital Expenditure | -2,237.50% | -7,190.00% | -16,930.69% | -5,061.22% | 31.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 2,096.76% | 1,300.61% | 203.06% | -420.27% |
| Cash from Investing | 97.22% | 1,620.51% | 1,184.90% | -4,708.48% | -422.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.72% | -83.42% | -59.26% | -90.57% | 6,880.19% |
| Repurchase of Common Stock | -2,540.89% | -1,138.37% | -382.02% | -- | -77.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -108.49% | -298.54% | -112.52% | 969.54% | 7,778.38% |
| Foreign Exchange rate Adjustments | -- | -- | 13.33% | -25.00% | 1,100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.50% | 29.71% | 1,695.78% | -1,729.55% | 1,485.34% |